2027 ICD-10-CM Diagnosis Code L94.5Poikiloderma vasculare atrophicans
ICD-10-CM Codes›L00–L99›L80-L99›L94
- Billable — Valid for Submission
- Chronic Condition
L94.5 is a billable ICD-10-CM diagnosis code for poikiloderma vasculare atrophicans. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 595 through 596. Coders also document this condition as cell-mediated cytotoxic reaction. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified connective tissue disease and Other specified inflammatory condition of skin.
L94.5 does not risk-adjust for Medicare Advantage under the CMS-HCC V28 model. It still risk-adjusts in the RxHCC Part D (V08) category 316 for payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
L94.5 does not risk-adjust for Medicare Advantage under the CMS-HCC V28 model, but it maps to payment categories in the other CMS models shown below.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cell-mediated cytotoxic reaction
- Parapsoriasis
- Parapsoriasis lichenoides
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to L94.5: its own notes plus those printed at L94 and Chapter 12. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- lipomelanotic reticulosis (I89.8)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- viral warts (B07.-)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name L94.5, its category, or a range that includes it.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Skin Conditions
Your skin is your body's largest organ. It covers the entire outside of your body. There are many ways that your skin protects your body and helps keep you healthy. For example, it:
The full article covers:
- What does your skin do?
- What problems and conditions can affect your skin?
- How can I keep my skin healthy?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert L94.5 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About L94.5Overview
What is the ICD-10 code for poikiloderma vasculare atrophicans?
The ICD-10-CM code for poikiloderma vasculare atrophicans is L94.5 (sometimes written as L945). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is L94.5 (Other localized connective tissue disorders) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report poikiloderma vasculare atrophicans on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does L94.5 group to?
When poikiloderma vasculare atrophicans is the principal diagnosis on an inpatient stay, it groups to MS-DRG 596, 595, with relative weights from 1.1067 to 2.0230 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of L94.5?
Under the General Equivalence Mappings, poikiloderma vasculare atrophicans converts to ICD-9-CM 696.2 (parapsoriasis). The mapping is approximate, so confirm the match fits the documentation.
Does L94.5 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage: L94.5 maps to no category in the CMS-HCC V28 model. It still risk-adjusts in the RxHCC Part D (V08) category 316 (Psoriasis, Except with Arthropathy).